Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Christine Piguet

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Hepatology|December 21, 2010
PI(3)K/PTEN/AKT pathwayAnne-Christine Piguet, Jean-François Dufour
Clinical Science (London, England : 1979)|February 28, 2008
Targeting vessels to treat hepatocellular carcinomaPamela Romanque, Anne-Christine Piguet, Jean-François Dufour
European Journal of Pharmacology|March 5, 2013
Study of the cellular mechanism of Sunitinib mediated inactivation of activated hepatic stellate cells and its implications in angiogenesisSyamantak Majumder, Anne-Christine Piguet, Jean-François Dufour, et al.
Clinical Science (London, England : 1979)|October 17, 2009
Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTENAnne-Christine Piguet, Deborah Stroka, Arthur Zimmermann, et al.
Journal of Hepatology|July 17, 2012
Rapamycin impacts positively on longevity, despite glucose intolerance inductionAnne-Christine Piguet, Paulo J F Martins, Sara C Kozma
Hepatology (Baltimore, Md.)|April 30, 2005
Activation of CREB by tauroursodeoxycholic acid protects cholangiocytes from apoptosis induced by mTOR inhibitionLifu Wang, Anne-Christine Piguet, Karin Schmidt, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 28, 2019
Hepatic gene expression in mouse models of non-alcoholic fatty liver disease after acute exerciseAnne-Christine Piguet, Maria Guarino, Daniel P Potaczek, et al.
Journal of Drug Targeting|October 31, 2007
Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2Patrik Roth, Caroline Hammer, Anne-Christine Piguet, et al.
Clinical Science (London, England : 1979)|November 29, 2013
Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo, while demonstrating anti-angiogenic activitiesAnne-Christine Piguet, Syamantak Majumder, Uma Maheshwari, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 8, 2014
Virus-like particle-mediated intracellular delivery of mRNA cap analog with in vivo activity against hepatocellular carcinomaMonika Zochowska, Anne-Christine Piguet, Jacek Jemielity, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Hepatology|December 21, 2010
PI(3)K/PTEN/AKT pathwayAnne-Christine Piguet, Jean-François Dufour
Clinical Science (London, England : 1979)|February 28, 2008
Targeting vessels to treat hepatocellular carcinomaPamela Romanque, Anne-Christine Piguet, Jean-François Dufour
European Journal of Pharmacology|March 5, 2013
Study of the cellular mechanism of Sunitinib mediated inactivation of activated hepatic stellate cells and its implications in angiogenesisSyamantak Majumder, Anne-Christine Piguet, Jean-François Dufour, et al.
Clinical Science (London, England : 1979)|October 17, 2009
Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTENAnne-Christine Piguet, Deborah Stroka, Arthur Zimmermann, et al.
Journal of Hepatology|July 17, 2012
Rapamycin impacts positively on longevity, despite glucose intolerance inductionAnne-Christine Piguet, Paulo J F Martins, Sara C Kozma
Hepatology (Baltimore, Md.)|April 30, 2005
Activation of CREB by tauroursodeoxycholic acid protects cholangiocytes from apoptosis induced by mTOR inhibitionLifu Wang, Anne-Christine Piguet, Karin Schmidt, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 28, 2019
Hepatic gene expression in mouse models of non-alcoholic fatty liver disease after acute exerciseAnne-Christine Piguet, Maria Guarino, Daniel P Potaczek, et al.
Journal of Drug Targeting|October 31, 2007
Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2Patrik Roth, Caroline Hammer, Anne-Christine Piguet, et al.
Clinical Science (London, England : 1979)|November 29, 2013
Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo, while demonstrating anti-angiogenic activitiesAnne-Christine Piguet, Syamantak Majumder, Uma Maheshwari, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 8, 2014
Virus-like particle-mediated intracellular delivery of mRNA cap analog with in vivo activity against hepatocellular carcinomaMonika Zochowska, Anne-Christine Piguet, Jacek Jemielity, et al.
Pageof 3